| Drug Name |
Propylthiouracil |
| Drug ID |
BADD_D01869 |
| Description |
A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534) |
| Indications and Usage |
Used to manage hyperthyroidism which is due to an overactive thyroid gland (Grave's disease). |
| Marketing Status |
approved; investigational |
| ATC Code |
H03BA02 |
| DrugBank ID |
DB00550
|
| KEGG ID |
D00562
|
| MeSH ID |
D011441
|
| PubChem ID |
657298
|
| TTD Drug ID |
D00MIN
|
| NDC Product Code |
33342-314; 67253-651; 68084-964; 49452-6112; 20012-0001; 0228-2348; 70752-171; 59348-0013; 65319-1059 |
| UNII |
721M9407IY
|
| Synonyms |
Propylthiouracil | 6-Propyl-2-Thiouracil | 6 Propyl 2 Thiouracil |
